Your browser is no longer supported. Please, upgrade your browser.
DVAX Dynavax Technologies Corporation monthly Stock Chart
Dynavax Technologies Corporation
Index- P/E- EPS (ttm)-2.79 Insider Own0.36% Shs Outstand39.61M Perf Week-7.01%
Market Cap394.12M Forward P/E- EPS next Y-1.80 Insider Trans3.78% Shs Float38.40M Perf Month-10.68%
Income-113.00M PEG- EPS next Q-0.75 Inst Own91.60% Short Float24.07% Perf Quarter-35.52%
Sales5.50M P/S71.66 EPS this Y5.90% Inst Trans7.02% Short Ratio6.13 Perf Half Y-39.37%
Book/sh3.60 P/B2.76 EPS next Y39.20% ROA-55.60% Target Price35.33 Perf Year-55.95%
Cash/sh3.51 P/C2.84 EPS next 5Y- ROE-64.40% 52W Range9.80 - 29.86 Perf YTD-58.82%
Dividend- P/FCF- EPS past 5Y14.10% ROI-57.10% 52W High-66.68% Beta2.12
Dividend %- Quick Ratio5.20 Sales past 5Y-29.90% Gross Margin- 52W Low1.53% ATR0.70
Employees234 Current Ratio5.20 Sales Q/Q62.50% Oper. Margin- RSI (14)36.81 Volatility5.98% 7.47%
OptionableYes Debt/Eq0.00 EPS Q/Q6.40% Profit Margin- Rel Volume0.59 Prev Close10.05
ShortableYes LT Debt/Eq0.00 EarningsNov 03 BMO Payout- Avg Volume1.51M Price9.95
Recom2.30 SMA20-6.36% SMA50-19.75% SMA200-39.06% Volume884,753 Change-1.00%
Apr-28-16Downgrade RBC Capital Mkts Outperform → Sector Perform $48 → $17
Apr-27-16Downgrade JP Morgan Overweight → Neutral
Nov-30-15Initiated RBC Capital Mkts Outperform $48
Nov-25-13Upgrade MLV & Co Hold → Buy $1.50 → $5
Feb-25-13Downgrade MLV & Co Buy → Hold
Nov-16-12Reiterated MLV & Co Buy $10 → $7.50
Jan-04-12Initiated MLV & Co Buy $8
Nov-09-10Reiterated Wedbush Outperform $6 → $8
Nov-08-10Initiated Jefferies Buy $4
May-13-10Upgrade Wedbush Neutral → Outperform $2.60 → $6
Mar-20-09Initiated Wedbush Morgan Buy $1.20
Oct-22-08Downgrade Oppenheimer Outperform → Perform
May-19-08Reiterated Susquehanna Financial Positive $7 → $5
May-19-08Downgrade Bear Stearns Outperform → Peer Perform
Mar-18-08Downgrade Merriman Curhan Ford Buy → Neutral
Feb-22-08Upgrade Oppenheimer Perform → Outperform $8.50
Oct-03-07Initiated Credit Suisse Outperform $8
Jun-06-07Initiated Susquehanna Financial Positive
Feb-26-07Downgrade JMP Securities Mkt Outperform → Mkt Perform
Oct-27-16 08:15AM  Blog Coverage Dynavax Releases New Data Showing That its Vaccine HEPLISAV-B Offers Higher Seroprotection Against Hepatitis B Accesswire
08:02AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Sta
07:00AM  Dynavax Secures Committed Financing From Deerfield for $100 Million of Senior Secured Notes Marketwired
Oct-26-16 09:00AM  Dynavax Presents Data Showing That HEPLISAV-B Provides Significantly Higher Seroprotection Rates Against Hepatitis B Infection in Populations Known to Have a Reduced Immune Response to Currently Licensed Vaccines Marketwired
Oct-18-16 09:23AM  Biotech Review DVAX Vaccine Faces Crucial PDUFA Date, CLDX Seeks Fast-Track Orphan Drug Status CNW Group
Oct-16-16 11:45AM  What Will Dynavax Do if Heplisav-B Is Rejected? at Motley Fool
Oct-11-16 06:31AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Oct-09-16 07:00AM  Dynavax Presents Early Clinical Data From Lead Cancer Immunotherapy Candidate, SD-101, at ESMO Annual Congress Marketwired
Oct-07-16 02:51PM  Steven Cohen Increases Position in Dynavax
Oct-04-16 05:38PM  Why Dynavax Technologies Fell 13% Today at Motley Fool -12.90%
10:49AM  FDA Precedent Suggests Dynavax Hep B Vaccine Faces High Rejection Risk
Oct-03-16 06:41PM  Why Winnebago Industries, Janus Capital Group, and Dynavax Technologies Jumped Today at Motley Fool +18.97%
11:33AM  Why Allergan, eBay, Dynavax, KBR, and More Are Trending at Insider Monkey
06:32AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events
Sep-30-16 07:00AM  Biotech Stock Mailbag: Dynavax, Puma, Ariad
Sep-20-16 09:10AM  Dynavax Technologies Corp (DVAX): Glenhill Advisors Adds to Its Position at Insider Monkey
Sep-16-16 10:05AM  5 Stocks to Trade for Big Breakout Gains
Sep-14-16 10:02AM  How one investor is playing Dynavax
Sep-09-16 10:24AM  4 Biotechs Set to Provide a Shot in the Arm
Sep-07-16 10:56AM  Dynavax Rebounds on Same PDUFA Date for Heplisav BLA -8.14%
Sep-06-16 03:11PM  Why Dynavax Technologies Is Gaining Back 27% Today at Motley Fool +28.32%
12:29PM  Dynavax stock drops then gains 30% after canceled FDA drug review confounds investors at MarketWatch
12:17PM  Tuesdays Movers and Shakers: Cummins, Dynavax & More at Insider Monkey
10:34AM  Here's a Reason Why Dynavax Technologies (DVAX) Stock Is Soaring Today
10:25AM  ETFs with exposure to Dynavax Technologies Corp. : September 6, 2016
10:15AM  Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Dynavax Technologies Corporation (DVAX) PR Newswire
06:16AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:02AM  Biotech Movers and Shakers: Threshold Pharmaceuticals, Inc. (THLD) and Dynavax Technologies Corporation (DVAX) at Insider Monkey
Sep-05-16 08:31AM  Dynavax Technologies Corp. breached its 50 day moving average in a Bearish Manner : DVAX-US : September 5, 2016
08:00AM  VeriFone (PAY), Gilead (GILD) Among 5 Stocks That Hit 52-Week Lows Last Week at Insider Monkey
Sep-04-16 08:20PM  Dynavax Provides Regulatory Update on HEPLISAV-B Marketwired
Sep-03-16 01:46PM  VBI Vaccines: The Safer Alternative to the Struggling Dynavax Technologies
Sep-02-16 07:51PM  INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims against Dynavax Technologies Corporation and Advises Investors to Contact the Firm Business Wire -31.56%
06:25PM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Dynavax Technologies Corporation - DVAX Business Wire
05:11PM  Why Smith & Wesson, Dynavax Technologies, and Ambarella Slumped Today at Motley Fool
04:38PM  Why Dynavax Technologies Shares Crashed 32% Today at Motley Fool
04:04PM  Bristol-Myers, Verifone Dive into Fridays 52-Week Low Club at 24/7 Wall St.
03:14PM  Dynavax Plummets After FDA Cancels Advisory Panel for Vaccine at Bloomberg
03:08PM  Dynavax Technologies (DVAX) Stock Plummets on Cancelled FDA Meeting
Aug-25-16 10:11AM  ETFs with exposure to Dynavax Technologies Corp. : August 25, 2016
Aug-20-16 01:04PM  DYNAVAX TECHNOLOGIES CORP Financials
Aug-12-16 02:19PM  ETFs with exposure to Dynavax Technologies Corp. : August 12, 2016
Aug-10-16 12:18PM  Dynavax Technologies Corp. :DVAX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016
Aug-08-16 04:31PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial -6.81%
11:31AM  Looking At Dynavax Technologies Corporation (DVAX)s Upcoming Hep B Catalysts at Insider Monkey
06:33AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report
Aug-05-16 06:01PM  Dynavax Technologies reports 2Q loss
05:51PM  Dynavax Reports Second Quarter 2016 Financial Results Marketwired
05:31PM  Dynavax Announces FDA Advisory Committee Meeting to Review HEPLISAV-B Marketwired
09:47AM  5 Breakout Stocks to Buy for Big Gains
09:30AM  The Zacks Analyst Blog Highlights: Aratana Therapeutics, Dynavax Technologies, Heron Therapeutics and La Jolla Pharmaceutical
Aug-04-16 10:33AM  Drug Stocks' Earnings to Watch on Aug 5: PETX, DVAX & More
Jul-22-16 08:06AM  Dynavax Technologies Corp. breached its 50 day moving average in a Bullish Manner : DVAX-US : July 22, 2016
Jul-18-16 03:40PM  Dynavax Technologies Corp. Value Analysis (NASDAQ:DVAX) : July 18, 2016
Jul-13-16 09:29AM  Coverage Initiated on Select Biotech Stocks
Jul-11-16 08:37AM  Dynavax Technologies Corp. breached its 50 day moving average in a Bullish Manner : DVAX-US : July 11, 2016
Jul-09-16 05:21PM  Why Dynavax Technologies Shares Slid 12% in June at Motley Fool
Jun-15-16 07:12AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jun-11-16 11:00AM  Dynavax Presents New Efficacy Data on Hepatitis B Vaccine, HEPLISAV-B(TM), in Adults With Type 2 Diabetes at ADA Scientific Sessions Marketwired
May-31-16 04:29PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-19-16 07:18PM  ETFs with exposure to Dynavax Technologies Corp. : May 19, 2016
May-18-16 07:00AM  Dynavax to Present at Two Upcoming Investor Conferences Marketwired
May-17-16 02:30PM  Dynavax Technologies Corp. :DVAX-US: Earnings Analysis: Q1, 2016 By the Numbers
May-09-16 06:10PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and +6.96%
06:04PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report
09:05AM  Dynavax Technologies reports 1Q loss
09:00AM  Dynavax Reports First Quarter 2016 Financial Results Marketwired
May-03-16 08:40AM  Does This Upstart Pose a Threat to GlaxoSmithKline? at Motley Fool
Apr-29-16 02:11PM  ETFs with exposure to Dynavax Technologies Corp. : April 29, 2016 at Capital Cube -6.39%
Apr-28-16 08:19AM  Dynavax Technologies Corp. breached its 50 day moving average in a Bearish Manner : DVAX-US : April 28, 2016 at Capital Cube -5.40%
06:16AM  Dynavax downgraded by RBC Capital Mkts
Apr-27-16 04:19PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online -11.68%
02:04PM  Why Dynavex Technologies Shares Are Crashing Today at Motley Fool
12:01PM  Why Traders Are Selling These Five Tanking Stocks? at Insider Monkey
07:00AM  Dynavax Receives Notification of PDUFA Extension for HEPLISAV-B to December 15, 2016 Marketwired
Apr-21-16 10:43AM  3 Biotech Stocks I'd Buy Right Now at Motley Fool
Apr-19-16 04:31PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Stat
Apr-18-16 04:02PM  Dynavax Presents Pivotal Phase 3 Data Showing HEPLISAV-B(TM) Provides Significantly Higher Protection Against Hepatitis B Than Engerix-B(R) Marketwired
04:02PM  Dynavax Presents Encouraging Data From Clinical Trial of Immuno-Oncology Product Candidate, SD-101 Marketwired
Apr-12-16 09:02AM  3 Biotech Stocks to Buy in April at Motley Fool
Apr-09-16 03:24PM  Here's Why Dynavax Technologies Corporation's Stock Gained 14.5% In March at Motley Fool
Apr-08-16 10:05AM  How Risky Is Dynavax Technologies Stock? at Motley Fool
Apr-05-16 03:37PM  Dynavax Technologies Corp. Value Analysis (NASDAQ:DVAX) : April 5, 2016
Apr-04-16 07:00PM  Lightning Round: This group cannot be bought at CNBC +6.25%
08:04AM  Dynavax Technologies Corp. breached its 50 day moving average in a Bullish Manner : DVAX-US : April 4, 2016
07:00AM  Dynavax to Present Data From Pivotal Phase 3 HEPLISAV-B(TM) Trial Marketwired
Mar-31-16 04:16PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits +6.59%
03:02PM  Here's Why Dynavax Technologies (DVAX) Stock is Climbing Today at TheStreet
Mar-30-16 05:13PM  Dynavax Announces FDA Acceptance for Review of Biologics License Application and PDUFA Action Date for HEPLISAV-B(TM) Marketwired
Mar-17-16 07:00AM  Dynavax Announces Data Presentations at AACR Annual Meeting Marketwired
Mar-16-16 12:50PM  4 More Key FDA Decisions in March at 24/7 Wall St.
Mar-14-16 03:30PM  ETFs with exposure to Dynavax Technologies Corp. : March 14, 2016
10:13AM  Dynavax Technologies Corp. :DVAX-US: Earnings Analysis: Q4, 2015 By the Numbers
Mar-12-16 09:47AM  Dynavax Technologies Corporation's Stock Got Crushed in February -- Time to Buy? at Motley Fool
Mar-09-16 04:04PM  The 52-Week Low Club for Wednesday at 24/7 Wall St.
Mar-08-16 04:56PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and -6.54%
04:49PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-K, Annual Report
07:21AM  Dynavax Technologies reports 4Q loss
07:00AM  Dynavax Reports Fourth Quarter and Year End 2015 Financial Results Marketwired
Mar-02-16 04:05PM  Dynavax to Participate in the Cowen and Company 36th Annual Health Care Conference
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the United States. Its development programs focuses on vaccine adjuvants, cancer immunotherapy, and autoimmune and inflammatory diseases. The company's lead products include HEPLISAV-B, an investigational adult hepatitis B vaccine, which is in Phase III clinical trials; and SD-101, a C Class CpG TLR9 agonist for the treatment of cancer, which is in Phase I/II multicenter clinical trial. Its product portfolio also comprises AZD1419 for the treatment of asthma, which is in Phase II clinical trial; DV1179, a TLR7/9 inhibitor that is in Phase Ib/IIa for the treatment of autoimmune and inflammatory conditions; and DV281 and CpG-Nanoparticles, which are in preclinical studies for cancer immunotherapy. It has a research collaboration and license agreement with AstraZeneca AB to conduct a Phase IIa safety and efficacy trial of AZD1419 for the treatment of asthma; and strategic alliance with GlaxoSmithKline to discover, develop, and commercialize TLR inhibitors. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Janssen RobertVice PresidentJun 28Buy13.681,45219,8636,048Jun 30 06:51 AM
Gray EddieCEO and DirectorMay 20Buy15.572,75042,8205,250May 23 09:10 AM
Janssen RobertVice PresidentMay 12Buy15.121,00015,1201,000May 13 09:30 AM